Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

Life Sciences

Volumn 58, Issue 6, 1996, Pages

  Santucci, Vincent ^a   Storme, Jean Jacques ^a   Soubrié, Philippe ^a   Le Fur, Gérard ^a  

^a SANOFI   (France)

Author keywords

Cannabinoid receptor antagonist; Electroencephalogram; Sleep waking cycle; SR 141716A

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; NONHUMAN; POWER SPECTRUM; RAT; REM SLEEP; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

ANIMALS; AROUSAL; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SLEEP; WAKEFULNESS;

ANIMALIA;

EID: 0030028250     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(95)02319-4     Document Type: Article

References (20)

1. S. MUNRO, K.L. THOMAS and M. ABU-SHAAR, Nature 365 61-65 (1993).
2. A.C. HOWLETT, M. BIDAUT-RUSSELL, W.A. DEVANE, L.S. MELVIN, M. ROSS JOHNSON and M. HERKENHAM, Trends in Neurosci. 13 420-423 (1990).
3. M. BUONAMICI, G.A. YOUNG and N. KHAZAN, Neuropharmacology 21 825-829 (1982).
4. F.C. TORTELLA, L. ROBLES, J. ROSE and S.J. WARD, Br. J. Pharmacol. proc. suppl. 112 616P (1994).
5. J.E. MORETON and W.M. DAVIS, Neuropharmacology 12 897-907 (1973).
6. F.R. FREEMON, Psychopharmacologia (Berlin) 35 39-44 (1974).
7. M. HERKENHAM, A.B. LYNN, M.D. LITTLE, M. ROSS JOHNSON, L.S. MELVIN, B.R. DE COSTA and K.C. RICE, Proc. Natl. Acad. Sci. USA 87 1932-1936 (1990).
8. W.A. DEVANE, L. HANUS, A. BREUER, R.G. PERTWEE, L.A. STEVENSON, G. GRIFFIN, D. GIBSON, A. MANDELBAUM, A. ETINGER and R. MECHOULAM, Science 258 1946-1949 (1992).
9. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, C. CONGY, S. MARTINEZ, J. MARUANI, G. NELIAT, D. CAPUT, P. FERRARA, P. SOUBRIE, J.-C. BRELIERE and G. LE FUR, FEBS Letters 350 240-244 (1994).
10. C. GUEUDET, V. SANTUCCI, M. RINALDI-CARMONA, P. SOUBRIE and G. LE FUR, Neuroreport 6 1421-1425 (1995).
11. M. RINALDI-CARMONA, C. CONGY, V. SANTUCCI, J. SIMIAND, B. GAUTRET, G. NELIAT, B. LABEEUW, G. LE FUR, P. SOUBRIE and J.-C. BRELIERE, J. Pharmacol. Exp. Ther. 262 759-768 (1992).
12. J. SOUILHAC, M. PONCELET, M. RINALDI-CARMONA, G. LE FUR and P. SOUBRIE, Pharmacol. Biochem. Behav. 51 3-7 (1995).
13. V. SANTUCCI, M. FOURNIER, P. WORMS, P. KEANE and K. BIZIERE, Naunyn-Schmiedeberg's Arch. Pharmacol. 340 93-100 (1989).
14. P.M. GROVES and J.M. TEPPER, Stimulants: Neurochemical, Behavioral and Clinical Perspectives, I. Creese (Ed), 81-129, Raven Press, New York (1983).
15. P. SKOLNICK, M.M. SCHWERI, S.M. PAUL, J.V. MARTIN, R.L. WAGNER and W.B. MENDELSON, Life Sci. 32 2439-2445 (1983).
16. E. SCHWAM, K. KEIM, R. CUMIN, E. GAMZU and J. SEPINWALL, Ann. N.Y. Acad. Sci. 444 482-484 (1985).
17. P.R. BIECK, K.H. ANTONIN, C. BRITZELMEIER, C. CREMER, C. GLEITER, E. NILSSON and W. SCHOENLEBER, Clin. Neuropharmacol. 7 (Suppl. 1) 674-675 (1984).
18. D.M. EDGAR, W.F. SEIDEL, P.C. CONTRERAS, J.L. VAUGHT and W.C. DEMENT, Can. J. Physiol. Pharmacol. 72 362 (1994).
19. M. STERIADE, P. GLOOR, R.R. LLINAS, F.H. LOPES DA SILVA and M.-M. MESULAM, Electroenceph. Clin. Neurophysiol. 76 481-508 (1990).
20. E.M. JANSEN, D.A. HAYCOCK, S.J. WARD and V.S. SEYBOLD, Brain Res. 575 93-102 (1992).